Correction: Dishevelled1-3 contribute to multidrug resistance in colorectal cancer via activating Wnt/β-catenin signaling
Metrics: PDF 278 views | ?
1School of Biomedical Sciences, Chengdu Medical College, Chengdu, 610041, Sichuan, China
2School of Basic Medical Sciences, Chengdu Medical College, Chengdu, 610041, Sichuan, China
*These authors contributed equally to this work
Published: November 23, 2021
Copyright: © 2021 Zhang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article has been corrected: In Figure 2E, the MRP2 blot panel was inadvertently duplicated in the BCRP blot panel. The corrected Figure 2E, produced using the original data, is shown below. The authors declare that these corrections do not change the results or conclusions of this paper.
Original article: Oncotarget. 2017; 8:115803–115816. DOI: https://doi.org/10.18632/oncotarget.23253
Figure 2: DVL increased expressions of P-gp, MRP2 and BCRP. (E) HCT-8/VCR cells transfected with shNC, shDVL, or shDVL plus pcDNA3.1-Flag-DVL for 72 h, were lysed to examine the protein levels of P-gp, MRP2 and BCRP, Flag-DVL1-3 and DVL1-3 using Western blotting. In each case, the blot was representative of immunoblots resulting from three separate experiments.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.